Business Wire

Study: Testosterone Pellet Therapy Significantly Improves Bone Density in Male Patient Case Report

IRVING, Texas--(BUSINESS WIRE)--In a case study, a 54-year-old male patient with a spontaneous fracture and osteoporosis achieved an “almost complete recovery of osteoporosis” after one year of ...
Yahoo Finance

BioCorRx Receives FDA Clearance of Investigational New Drug (IND) Application for BICX104, its Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder

ANAHEIM, CA, May 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire-- BioCorRx Inc. (OTCQB: BICX) (“BioCorRx” or the “Company”), a developer and provider of advanced solutions in the treatment of substance ...
Seeking Alpha

BioCorRx Submits Expanded Access Treatment Protocol to FDA for BICX104, Implantable Biodegradable Naltrexone Pellet for Treatment of Opioid Use Disorder

Company Hopes in 30 Days to Begin Making Its Drug Candidate Available to Help Patients and Address Public Health Crisis Brady Granier, President of BioCorRx, Inc., and CEO of BioCorRx Pharmaceuticals, ...
JSTOR Daily

Subcutaneous Implantation of Cortisone Pellets in Rheumatoid Arthritis

Science, founded by Thomas A. Edison in 1880 and published by AAAS, today ranks as the world's largest circulation general science journal. Published 51 times a year, Science is renowned for its ...
Benzinga.com

BICX: New Grant, Patent Filed

BioCorRx, Inc. BICX is at an early point in front of a vast market opportunity for medication assisted treatment (MAT) of opioid and alcohol use disorders. In September, the Company received a $3.5 ...